Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec 1;321(6):H1056-H1073.
doi: 10.1152/ajpheart.00459.2021. Epub 2021 Oct 8.

Guidelines for in vivo mouse models of myocardial infarction

Affiliations
Review

Guidelines for in vivo mouse models of myocardial infarction

Merry L Lindsey et al. Am J Physiol Heart Circ Physiol. .

Abstract

Despite significant improvements in reperfusion strategies, acute coronary syndromes all too often culminate in a myocardial infarction (MI). The consequent MI can, in turn, lead to remodeling of the left ventricle (LV), the development of LV dysfunction, and ultimately progression to heart failure (HF). Accordingly, an improved understanding of the underlying mechanisms of MI remodeling and progression to HF is necessary. One common approach to examine MI pathology is with murine models that recapitulate components of the clinical context of acute coronary syndrome and subsequent MI. We evaluated the different approaches used to produce MI in mouse models and identified opportunities to consolidate methods, recognizing that reperfused and nonreperfused MI yield different responses. The overall goal in compiling this consensus statement is to unify best practices regarding mouse MI models to improve interpretation and allow comparative examination across studies and laboratories. These guidelines will help to establish rigor and reproducibility and provide increased potential for clinical translation.

Keywords: cardiac; ischemia-reperfusion; myocardial infarction; rigor and reproducibility; rodent.

PubMed Disclaimer

Conflict of interest statement

M. L. Lindsey, K. R. Brunt, J. A. Kirk, P. Kleinbongard, C. M. Ripplinger, and Z. Kassiri are editors of AJP-Heart and Circ. Given their roles, none had any involvement in the peer review of this article outside of being authors and had no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Jason Carter.

Figures

Figure 1.
Figure 1.
Key differences between reperfused myocardial infarction (MI) and nonreperfused MI, including differences in infarct sizes, study goals, structural and physiological responses, survival, and cell and molecular signaling. For the reperfused heart, the mid-myocardial section was stained with Evans blue (in vivo) and 1% triphenyltetrazolium chloride (ex vivo) to show the necrotic zone (NEC; white), nonischemic zone (NIZ; blue), and ischemic zone (IZ; red and white) (41). For the nonreperfused heart, the ventricles were sectioned from base (left) to apex (right) and stained with 1% triphenyltetrazolium chloride, which stains viable myocardium red and infarct is white (42). Images are reproduced with permission from the American Journal of Physiology-Heart and Circulatory Physiology.

References

    1. Frangogiannis NG. Pathophysiology of myocardial infarction. Compr Physiol 5: 1841–1875, 2015. doi:10.1002/cphy.c150006. - DOI - PubMed
    1. Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. . Heart Disease and Stroke Statistics-2021 Update: a report from the American Heart Association. Circulation 143: e254–e743, 2021. doi:10.1161/CIR.0000000000000950. - DOI - PubMed
    1. Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet 389: 197–210, 2017. [Erratum in Lancet 389: 156, 2017]. doi:10.1016/S0140-6736(16)30677-8. - DOI - PubMed
    1. Lindsey ML, de Castro Brás LE, DeLeon-Pennell KY, Frangogiannis NG, Halade GV, O'Meara CC, Spinale FG, Kassiri Z, Kirk JA, Kleinbongard P, Ripplinger CM, Brunt KR. Reperfused vs. nonreperfused myocardial infarction: when to use which model. Am J Physiol Heart Circ Physiol 321: H208–H213, 2021. doi:10.1152/ajpheart.00234.2021. - DOI - PMC - PubMed
    1. Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 105: 656–662, 2002. doi:10.1161/hc0502.102867. - DOI - PubMed

Publication types

MeSH terms